Company Filing History:
3 out of 2,345 
2 out of 1,736 
Years Active: 2021-2024
Title: Kevin Gorman: Innovator in Affinity Reagent Technologies
Introduction
Kevin Gorman is a notable inventor based in Chicago, IL, who has made significant contributions to the field of affinity reagents. With a total of three patents to his name, Gorman's work focuses on improving the methods for screening and generating high-affinity binding agents.
Latest Patents
Gorman's latest patents include innovative methods for generating recombinant affinity reagents with arrayed targets. This method allows for the simultaneous screening of affinity reagents for multiple target proteins, enhancing the efficiency of discovering these reagents. Another significant patent involves a combined Kunkel mutagenesis and phage-display method for producing high-affinity, bivalent binding agents specifically designed for sandwich assays.
Career Highlights
Throughout his career, Gorman has worked with prestigious institutions such as the University of Illinois and Arizona State University. His research has contributed to advancements in the field of biotechnology, particularly in the development of affinity reagents.
Collaborations
Gorman has collaborated with notable colleagues, including Brian Kay and Joshua LaBaer, further enriching his research and innovation efforts.
Conclusion
Kevin Gorman's contributions to the field of affinity reagents demonstrate his commitment to advancing biotechnology. His innovative patents and collaborations highlight his role as a key figure in this area of research.